0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global IL-4Rα Targeting Drugs Market Research Report 2024
Published Date: July 2024
|
Report Code: QYRE-Auto-5V17633
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global IL 4Rα Targeting Drugs Market Research Report 2024
BUY CHAPTERS

Global IL-4Rα Targeting Drugs Market Research Report 2024

Code: QYRE-Auto-5V17633
Report
July 2024
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

IL-4Rα Targeting Drugs Market

Interleukin-4 (IL-4) is a glycosylated type I cytokine with a molecular size of approximately 20 kD, three intrachain disulfide bonds, and a bundled four-alpha helical structure. It is mainly produced by activated T cells, mast cells, eosinophils, and basophils. IL-4 has immunoregulatory effects on B cells, T cells, mast cells, macrophages, and hematopoietic cells, and is very important for the development of T and B lymphocytes and for driving humoral immune responses and antibody production.
The global IL-4Rα Targeting Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for IL-4Rα Targeting Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for IL-4Rα Targeting Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of IL-4Rα Targeting Drugs include Regeneron, Sanofi, Sunshine Guojian, Qingzhixiang Jintai Biopharmaceuticals, Conoya Biopharmaceuticals, Connaide Biopharmaceuticals, Kengfang Biopharmaceuticals, Hengrui Medical, AstraZeneca, Innovent Biologics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for IL-4Rα Targeting Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding IL-4Rα Targeting Drugs.
The IL-4Rα Targeting Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global IL-4Rα Targeting Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the IL-4Rα Targeting Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of IL-4Rα Targeting Drugs Market Report

Report Metric Details
Report Name IL-4Rα Targeting Drugs Market
Segment by Type
  • Monoclonal Antibodies
  • Fusion Proteins
  • Small Molecule Inhibitors
  • Vaccines
Segment by Application
  • Atopic Dermatitis
  • Asthma
  • Chronic Sinusitis with Nasal Polyps
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Regeneron, Sanofi, Sunshine Guojian, Qingzhixiang Jintai Biopharmaceuticals, Conoya Biopharmaceuticals, Connaide Biopharmaceuticals, Kengfang Biopharmaceuticals, Hengrui Medical, AstraZeneca, Innovent Biologics, Numab Therapeutics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of IL-4Rα Targeting Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of IL-4Rα Targeting Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the IL-4Rα Targeting Drugs Market report?

Ans: The main players in the IL-4Rα Targeting Drugs Market are Regeneron, Sanofi, Sunshine Guojian, Qingzhixiang Jintai Biopharmaceuticals, Conoya Biopharmaceuticals, Connaide Biopharmaceuticals, Kengfang Biopharmaceuticals, Hengrui Medical, AstraZeneca, Innovent Biologics, Numab Therapeutics

What are the Application segmentation covered in the IL-4Rα Targeting Drugs Market report?

Ans: The Applications covered in the IL-4Rα Targeting Drugs Market report are Atopic Dermatitis, Asthma, Chronic Sinusitis with Nasal Polyps, Other

What are the Type segmentation covered in the IL-4Rα Targeting Drugs Market report?

Ans: The Types covered in the IL-4Rα Targeting Drugs Market report are Monoclonal Antibodies, Fusion Proteins, Small Molecule Inhibitors, Vaccines

1 IL-4Rα Targeting Drugs Market Overview
1.1 Product Definition
1.2 IL-4Rα Targeting Drugs by Type
1.2.1 Global IL-4Rα Targeting Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Monoclonal Antibodies
1.2.3 Fusion Proteins
1.2.4 Small Molecule Inhibitors
1.2.5 Vaccines
1.3 IL-4Rα Targeting Drugs by Application
1.3.1 Global IL-4Rα Targeting Drugs Market Value by Application (2024-2030)
1.3.2 Atopic Dermatitis
1.3.3 Asthma
1.3.4 Chronic Sinusitis with Nasal Polyps
1.3.5 Other
1.4 Global IL-4Rα Targeting Drugs Market Size Estimates and Forecasts
1.4.1 Global IL-4Rα Targeting Drugs Revenue 2019-2030
1.4.2 Global IL-4Rα Targeting Drugs Sales 2019-2030
1.4.3 Global IL-4Rα Targeting Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 IL-4Rα Targeting Drugs Market Competition by Manufacturers
2.1 Global IL-4Rα Targeting Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global IL-4Rα Targeting Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global IL-4Rα Targeting Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of IL-4Rα Targeting Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of IL-4Rα Targeting Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of IL-4Rα Targeting Drugs, Product Type & Application
2.7 Global Key Manufacturers of IL-4Rα Targeting Drugs, Date of Enter into This Industry
2.8 Global IL-4Rα Targeting Drugs Market Competitive Situation and Trends
2.8.1 Global IL-4Rα Targeting Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest IL-4Rα Targeting Drugs Players Market Share by Revenue
2.8.3 Global IL-4Rα Targeting Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global IL-4Rα Targeting Drugs Market Scenario by Region
3.1 Global IL-4Rα Targeting Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global IL-4Rα Targeting Drugs Sales by Region: 2019-2030
3.2.1 Global IL-4Rα Targeting Drugs Sales by Region: 2019-2024
3.2.2 Global IL-4Rα Targeting Drugs Sales by Region: 2025-2030
3.3 Global IL-4Rα Targeting Drugs Revenue by Region: 2019-2030
3.3.1 Global IL-4Rα Targeting Drugs Revenue by Region: 2019-2024
3.3.2 Global IL-4Rα Targeting Drugs Revenue by Region: 2025-2030
3.4 North America IL-4Rα Targeting Drugs Market Facts & Figures by Country
3.4.1 North America IL-4Rα Targeting Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America IL-4Rα Targeting Drugs Sales by Country (2019-2030)
3.4.3 North America IL-4Rα Targeting Drugs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe IL-4Rα Targeting Drugs Market Facts & Figures by Country
3.5.1 Europe IL-4Rα Targeting Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe IL-4Rα Targeting Drugs Sales by Country (2019-2030)
3.5.3 Europe IL-4Rα Targeting Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific IL-4Rα Targeting Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific IL-4Rα Targeting Drugs Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific IL-4Rα Targeting Drugs Sales by Region (2019-2030)
3.6.3 Asia Pacific IL-4Rα Targeting Drugs Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America IL-4Rα Targeting Drugs Market Facts & Figures by Country
3.7.1 Latin America IL-4Rα Targeting Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America IL-4Rα Targeting Drugs Sales by Country (2019-2030)
3.7.3 Latin America IL-4Rα Targeting Drugs Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa IL-4Rα Targeting Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa IL-4Rα Targeting Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa IL-4Rα Targeting Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa IL-4Rα Targeting Drugs Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global IL-4Rα Targeting Drugs Sales by Type (2019-2030)
4.1.1 Global IL-4Rα Targeting Drugs Sales by Type (2019-2024)
4.1.2 Global IL-4Rα Targeting Drugs Sales by Type (2025-2030)
4.1.3 Global IL-4Rα Targeting Drugs Sales Market Share by Type (2019-2030)
4.2 Global IL-4Rα Targeting Drugs Revenue by Type (2019-2030)
4.2.1 Global IL-4Rα Targeting Drugs Revenue by Type (2019-2024)
4.2.2 Global IL-4Rα Targeting Drugs Revenue by Type (2025-2030)
4.2.3 Global IL-4Rα Targeting Drugs Revenue Market Share by Type (2019-2030)
4.3 Global IL-4Rα Targeting Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global IL-4Rα Targeting Drugs Sales by Application (2019-2030)
5.1.1 Global IL-4Rα Targeting Drugs Sales by Application (2019-2024)
5.1.2 Global IL-4Rα Targeting Drugs Sales by Application (2025-2030)
5.1.3 Global IL-4Rα Targeting Drugs Sales Market Share by Application (2019-2030)
5.2 Global IL-4Rα Targeting Drugs Revenue by Application (2019-2030)
5.2.1 Global IL-4Rα Targeting Drugs Revenue by Application (2019-2024)
5.2.2 Global IL-4Rα Targeting Drugs Revenue by Application (2025-2030)
5.2.3 Global IL-4Rα Targeting Drugs Revenue Market Share by Application (2019-2030)
5.3 Global IL-4Rα Targeting Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Regeneron
6.1.1 Regeneron Company Information
6.1.2 Regeneron Description and Business Overview
6.1.3 Regeneron IL-4Rα Targeting Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Regeneron IL-4Rα Targeting Drugs Product Portfolio
6.1.5 Regeneron Recent Developments/Updates
6.2 Sanofi
6.2.1 Sanofi Company Information
6.2.2 Sanofi Description and Business Overview
6.2.3 Sanofi IL-4Rα Targeting Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi IL-4Rα Targeting Drugs Product Portfolio
6.2.5 Sanofi Recent Developments/Updates
6.3 Sunshine Guojian
6.3.1 Sunshine Guojian Company Information
6.3.2 Sunshine Guojian Description and Business Overview
6.3.3 Sunshine Guojian IL-4Rα Targeting Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sunshine Guojian IL-4Rα Targeting Drugs Product Portfolio
6.3.5 Sunshine Guojian Recent Developments/Updates
6.4 Qingzhixiang Jintai Biopharmaceuticals
6.4.1 Qingzhixiang Jintai Biopharmaceuticals Company Information
6.4.2 Qingzhixiang Jintai Biopharmaceuticals Description and Business Overview
6.4.3 Qingzhixiang Jintai Biopharmaceuticals IL-4Rα Targeting Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Qingzhixiang Jintai Biopharmaceuticals IL-4Rα Targeting Drugs Product Portfolio
6.4.5 Qingzhixiang Jintai Biopharmaceuticals Recent Developments/Updates
6.5 Conoya Biopharmaceuticals
6.5.1 Conoya Biopharmaceuticals Company Information
6.5.2 Conoya Biopharmaceuticals Description and Business Overview
6.5.3 Conoya Biopharmaceuticals IL-4Rα Targeting Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Conoya Biopharmaceuticals IL-4Rα Targeting Drugs Product Portfolio
6.5.5 Conoya Biopharmaceuticals Recent Developments/Updates
6.6 Connaide Biopharmaceuticals
6.6.1 Connaide Biopharmaceuticals Company Information
6.6.2 Connaide Biopharmaceuticals Description and Business Overview
6.6.3 Connaide Biopharmaceuticals IL-4Rα Targeting Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Connaide Biopharmaceuticals IL-4Rα Targeting Drugs Product Portfolio
6.6.5 Connaide Biopharmaceuticals Recent Developments/Updates
6.7 Kengfang Biopharmaceuticals
6.7.1 Kengfang Biopharmaceuticals Company Information
6.7.2 Kengfang Biopharmaceuticals Description and Business Overview
6.7.3 Kengfang Biopharmaceuticals IL-4Rα Targeting Drugs Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Kengfang Biopharmaceuticals IL-4Rα Targeting Drugs Product Portfolio
6.7.5 Kengfang Biopharmaceuticals Recent Developments/Updates
6.8 Hengrui Medical
6.8.1 Hengrui Medical Company Information
6.8.2 Hengrui Medical Description and Business Overview
6.8.3 Hengrui Medical IL-4Rα Targeting Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Hengrui Medical IL-4Rα Targeting Drugs Product Portfolio
6.8.5 Hengrui Medical Recent Developments/Updates
6.9 AstraZeneca
6.9.1 AstraZeneca Company Information
6.9.2 AstraZeneca Description and Business Overview
6.9.3 AstraZeneca IL-4Rα Targeting Drugs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 AstraZeneca IL-4Rα Targeting Drugs Product Portfolio
6.9.5 AstraZeneca Recent Developments/Updates
6.10 Innovent Biologics
6.10.1 Innovent Biologics Company Information
6.10.2 Innovent Biologics Description and Business Overview
6.10.3 Innovent Biologics IL-4Rα Targeting Drugs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Innovent Biologics IL-4Rα Targeting Drugs Product Portfolio
6.10.5 Innovent Biologics Recent Developments/Updates
6.11 Numab Therapeutics
6.11.1 Numab Therapeutics Company Information
6.11.2 Numab Therapeutics Description and Business Overview
6.11.3 Numab Therapeutics IL-4Rα Targeting Drugs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Numab Therapeutics IL-4Rα Targeting Drugs Product Portfolio
6.11.5 Numab Therapeutics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 IL-4Rα Targeting Drugs Industry Chain Analysis
7.2 IL-4Rα Targeting Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 IL-4Rα Targeting Drugs Production Mode & Process
7.4 IL-4Rα Targeting Drugs Sales and Marketing
7.4.1 IL-4Rα Targeting Drugs Sales Channels
7.4.2 IL-4Rα Targeting Drugs Distributors
7.5 IL-4Rα Targeting Drugs Customers
8 IL-4Rα Targeting Drugs Market Dynamics
8.1 IL-4Rα Targeting Drugs Industry Trends
8.2 IL-4Rα Targeting Drugs Market Drivers
8.3 IL-4Rα Targeting Drugs Market Challenges
8.4 IL-4Rα Targeting Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global IL-4Rα Targeting Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global IL-4Rα Targeting Drugs Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global IL-4Rα Targeting Drugs Market Competitive Situation by Manufacturers in 2023
 Table 4. Global IL-4Rα Targeting Drugs Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global IL-4Rα Targeting Drugs Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global IL-4Rα Targeting Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global IL-4Rα Targeting Drugs Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market IL-4Rα Targeting Drugs Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of IL-4Rα Targeting Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of IL-4Rα Targeting Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of IL-4Rα Targeting Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of IL-4Rα Targeting Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global IL-4Rα Targeting Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IL-4Rα Targeting Drugs as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global IL-4Rα Targeting Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global IL-4Rα Targeting Drugs Sales by Region (2019-2024) & (K Units)
 Table 18. Global IL-4Rα Targeting Drugs Sales Market Share by Region (2019-2024)
 Table 19. Global IL-4Rα Targeting Drugs Sales by Region (2025-2030) & (K Units)
 Table 20. Global IL-4Rα Targeting Drugs Sales Market Share by Region (2025-2030)
 Table 21. Global IL-4Rα Targeting Drugs Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global IL-4Rα Targeting Drugs Revenue Market Share by Region (2019-2024)
 Table 23. Global IL-4Rα Targeting Drugs Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global IL-4Rα Targeting Drugs Revenue Market Share by Region (2025-2030)
 Table 25. North America IL-4Rα Targeting Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America IL-4Rα Targeting Drugs Sales by Country (2019-2024) & (K Units)
 Table 27. North America IL-4Rα Targeting Drugs Sales by Country (2025-2030) & (K Units)
 Table 28. North America IL-4Rα Targeting Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America IL-4Rα Targeting Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe IL-4Rα Targeting Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe IL-4Rα Targeting Drugs Sales by Country (2019-2024) & (K Units)
 Table 32. Europe IL-4Rα Targeting Drugs Sales by Country (2025-2030) & (K Units)
 Table 33. Europe IL-4Rα Targeting Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe IL-4Rα Targeting Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific IL-4Rα Targeting Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific IL-4Rα Targeting Drugs Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific IL-4Rα Targeting Drugs Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific IL-4Rα Targeting Drugs Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific IL-4Rα Targeting Drugs Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America IL-4Rα Targeting Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America IL-4Rα Targeting Drugs Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America IL-4Rα Targeting Drugs Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America IL-4Rα Targeting Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America IL-4Rα Targeting Drugs Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa IL-4Rα Targeting Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa IL-4Rα Targeting Drugs Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa IL-4Rα Targeting Drugs Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa IL-4Rα Targeting Drugs Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa IL-4Rα Targeting Drugs Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global IL-4Rα Targeting Drugs Sales (K Units) by Type (2019-2024)
 Table 51. Global IL-4Rα Targeting Drugs Sales (K Units) by Type (2025-2030)
 Table 52. Global IL-4Rα Targeting Drugs Sales Market Share by Type (2019-2024)
 Table 53. Global IL-4Rα Targeting Drugs Sales Market Share by Type (2025-2030)
 Table 54. Global IL-4Rα Targeting Drugs Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global IL-4Rα Targeting Drugs Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global IL-4Rα Targeting Drugs Revenue Market Share by Type (2019-2024)
 Table 57. Global IL-4Rα Targeting Drugs Revenue Market Share by Type (2025-2030)
 Table 58. Global IL-4Rα Targeting Drugs Price (US$/Unit) by Type (2019-2024)
 Table 59. Global IL-4Rα Targeting Drugs Price (US$/Unit) by Type (2025-2030)
 Table 60. Global IL-4Rα Targeting Drugs Sales (K Units) by Application (2019-2024)
 Table 61. Global IL-4Rα Targeting Drugs Sales (K Units) by Application (2025-2030)
 Table 62. Global IL-4Rα Targeting Drugs Sales Market Share by Application (2019-2024)
 Table 63. Global IL-4Rα Targeting Drugs Sales Market Share by Application (2025-2030)
 Table 64. Global IL-4Rα Targeting Drugs Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global IL-4Rα Targeting Drugs Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global IL-4Rα Targeting Drugs Revenue Market Share by Application (2019-2024)
 Table 67. Global IL-4Rα Targeting Drugs Revenue Market Share by Application (2025-2030)
 Table 68. Global IL-4Rα Targeting Drugs Price (US$/Unit) by Application (2019-2024)
 Table 69. Global IL-4Rα Targeting Drugs Price (US$/Unit) by Application (2025-2030)
 Table 70. Regeneron Company Information
 Table 71. Regeneron Description and Business Overview
 Table 72. Regeneron IL-4Rα Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Regeneron IL-4Rα Targeting Drugs Product
 Table 74. Regeneron Recent Developments/Updates
 Table 75. Sanofi Company Information
 Table 76. Sanofi Description and Business Overview
 Table 77. Sanofi IL-4Rα Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Sanofi IL-4Rα Targeting Drugs Product
 Table 79. Sanofi Recent Developments/Updates
 Table 80. Sunshine Guojian Company Information
 Table 81. Sunshine Guojian Description and Business Overview
 Table 82. Sunshine Guojian IL-4Rα Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Sunshine Guojian IL-4Rα Targeting Drugs Product
 Table 84. Sunshine Guojian Recent Developments/Updates
 Table 85. Qingzhixiang Jintai Biopharmaceuticals Company Information
 Table 86. Qingzhixiang Jintai Biopharmaceuticals Description and Business Overview
 Table 87. Qingzhixiang Jintai Biopharmaceuticals IL-4Rα Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Qingzhixiang Jintai Biopharmaceuticals IL-4Rα Targeting Drugs Product
 Table 89. Qingzhixiang Jintai Biopharmaceuticals Recent Developments/Updates
 Table 90. Conoya Biopharmaceuticals Company Information
 Table 91. Conoya Biopharmaceuticals Description and Business Overview
 Table 92. Conoya Biopharmaceuticals IL-4Rα Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Conoya Biopharmaceuticals IL-4Rα Targeting Drugs Product
 Table 94. Conoya Biopharmaceuticals Recent Developments/Updates
 Table 95. Connaide Biopharmaceuticals Company Information
 Table 96. Connaide Biopharmaceuticals Description and Business Overview
 Table 97. Connaide Biopharmaceuticals IL-4Rα Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Connaide Biopharmaceuticals IL-4Rα Targeting Drugs Product
 Table 99. Connaide Biopharmaceuticals Recent Developments/Updates
 Table 100. Kengfang Biopharmaceuticals Company Information
 Table 101. Kengfang Biopharmaceuticals Description and Business Overview
 Table 102. Kengfang Biopharmaceuticals IL-4Rα Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Kengfang Biopharmaceuticals IL-4Rα Targeting Drugs Product
 Table 104. Kengfang Biopharmaceuticals Recent Developments/Updates
 Table 105. Hengrui Medical Company Information
 Table 106. Hengrui Medical Description and Business Overview
 Table 107. Hengrui Medical IL-4Rα Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Hengrui Medical IL-4Rα Targeting Drugs Product
 Table 109. Hengrui Medical Recent Developments/Updates
 Table 110. AstraZeneca Company Information
 Table 111. AstraZeneca Description and Business Overview
 Table 112. AstraZeneca IL-4Rα Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. AstraZeneca IL-4Rα Targeting Drugs Product
 Table 114. AstraZeneca Recent Developments/Updates
 Table 115. Innovent Biologics Company Information
 Table 116. Innovent Biologics Description and Business Overview
 Table 117. Innovent Biologics IL-4Rα Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 118. Innovent Biologics IL-4Rα Targeting Drugs Product
 Table 119. Innovent Biologics Recent Developments/Updates
 Table 120. Numab Therapeutics Company Information
 Table 121. Numab Therapeutics Description and Business Overview
 Table 122. Numab Therapeutics IL-4Rα Targeting Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 123. Numab Therapeutics IL-4Rα Targeting Drugs Product
 Table 124. Numab Therapeutics Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. IL-4Rα Targeting Drugs Distributors List
 Table 128. IL-4Rα Targeting Drugs Customers List
 Table 129. IL-4Rα Targeting Drugs Market Trends
 Table 130. IL-4Rα Targeting Drugs Market Drivers
 Table 131. IL-4Rα Targeting Drugs Market Challenges
 Table 132. IL-4Rα Targeting Drugs Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of IL-4Rα Targeting Drugs
 Figure 2. Global IL-4Rα Targeting Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global IL-4Rα Targeting Drugs Market Share by Type: 2023 & 2030
 Figure 4. Monoclonal Antibodies Product Picture
 Figure 5. Fusion Proteins Product Picture
 Figure 6. Small Molecule Inhibitors Product Picture
 Figure 7. Vaccines Product Picture
 Figure 8. Global IL-4Rα Targeting Drugs Market Value by Application (2024-2030) & (US$ Million)
 Figure 9. Global IL-4Rα Targeting Drugs Market Share by Application: 2023 & 2030
 Figure 10. Atopic Dermatitis
 Figure 11. Asthma
 Figure 12. Chronic Sinusitis with Nasal Polyps
 Figure 13. Other
 Figure 14. Global IL-4Rα Targeting Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 15. Global IL-4Rα Targeting Drugs Market Size (2019-2030) & (US$ Million)
 Figure 16. Global IL-4Rα Targeting Drugs Sales (2019-2030) & (K Units)
 Figure 17. Global IL-4Rα Targeting Drugs Average Price (US$/Unit) & (2019-2030)
 Figure 18. IL-4Rα Targeting Drugs Report Years Considered
 Figure 19. IL-4Rα Targeting Drugs Sales Share by Manufacturers in 2023
 Figure 20. Global IL-4Rα Targeting Drugs Revenue Share by Manufacturers in 2023
 Figure 21. Global 5 and 10 Largest IL-4Rα Targeting Drugs Players: Market Share by Revenue in IL-4Rα Targeting Drugs in 2023
 Figure 22. IL-4Rα Targeting Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 23. Global IL-4Rα Targeting Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 24. North America IL-4Rα Targeting Drugs Sales Market Share by Country (2019-2030)
 Figure 25. North America IL-4Rα Targeting Drugs Revenue Market Share by Country (2019-2030)
 Figure 26. United States IL-4Rα Targeting Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 27. Canada IL-4Rα Targeting Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. Europe IL-4Rα Targeting Drugs Sales Market Share by Country (2019-2030)
 Figure 29. Europe IL-4Rα Targeting Drugs Revenue Market Share by Country (2019-2030)
 Figure 30. Germany IL-4Rα Targeting Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. France IL-4Rα Targeting Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. U.K. IL-4Rα Targeting Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Italy IL-4Rα Targeting Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Russia IL-4Rα Targeting Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. Asia Pacific IL-4Rα Targeting Drugs Sales Market Share by Region (2019-2030)
 Figure 36. Asia Pacific IL-4Rα Targeting Drugs Revenue Market Share by Region (2019-2030)
 Figure 37. China IL-4Rα Targeting Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. Japan IL-4Rα Targeting Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. South Korea IL-4Rα Targeting Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. India IL-4Rα Targeting Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Australia IL-4Rα Targeting Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. China Taiwan IL-4Rα Targeting Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Southeast Asia IL-4Rα Targeting Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Latin America IL-4Rα Targeting Drugs Sales Market Share by Country (2019-2030)
 Figure 45. Mexico IL-4Rα Targeting Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Brazil IL-4Rα Targeting Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Argentina IL-4Rα Targeting Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Colombia IL-4Rα Targeting Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Middle East and Africa IL-4Rα Targeting Drugs Sales Market Share by Country (2019-2030)
 Figure 50. Middle East and Africa IL-4Rα Targeting Drugs Revenue Market Share by Country (2019-2030)
 Figure 51. Turkey IL-4Rα Targeting Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Saudi Arabia IL-4Rα Targeting Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 53. UAE IL-4Rα Targeting Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 54. Global Sales Market Share of IL-4Rα Targeting Drugs by Type (2019-2030)
 Figure 55. Global Revenue Market Share of IL-4Rα Targeting Drugs by Type (2019-2030)
 Figure 56. Global IL-4Rα Targeting Drugs Price (US$/Unit) by Type (2019-2030)
 Figure 57. Global Sales Market Share of IL-4Rα Targeting Drugs by Application (2019-2030)
 Figure 58. Global Revenue Market Share of IL-4Rα Targeting Drugs by Application (2019-2030)
 Figure 59. Global IL-4Rα Targeting Drugs Price (US$/Unit) by Application (2019-2030)
 Figure 60. IL-4Rα Targeting Drugs Value Chain
 Figure 61. IL-4Rα Targeting Drugs Production Process
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD